$356 Million is the total value of Affinity Asset Advisors, LLC's 81 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AZN | ASTRAZENECA PLCsponsored adr | $4,063,200 | -5.4% | 60,000 | 0.0% | 1.14% | -23.8% | |
| VKTX | VIKING THERAPEUTICS INC | $3,321,000 | -31.7% | 300,000 | 0.0% | 0.93% | -45.0% | |
| MIRM | MIRUM PHARMACEUTICALS INC | $948,000 | +22.1% | 30,000 | 0.0% | 0.27% | -1.5% | |
| IMTXW | IMMATICS N.V*w exp 07/01/202 | $662,702 | +4.7% | 187,204 | 0.0% | 0.19% | -15.8% | |
| PBYI | PUMA BIOTECHNOLOGY INC | $532,178 | -25.5% | 202,349 | 0.0% | 0.15% | -39.8% | |
| NUVB | NUVATION BIO INC | $335,000 | -25.6% | 250,000 | 0.0% | 0.09% | -40.1% | |
| ROCKET PHARMACEUTICALS INC*w exp 09/02/202 | $7,500 | -46.1% | 75,000 | 0.0% | 0.00% | -60.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MORPHIC HOLDING INC | 12 | Q3 2023 | 6.9% |
| KURA ONCOLOGY INC | 12 | Q3 2023 | 7.2% |
| CELLDEX THERAPEUTICS INC NEW | 12 | Q3 2023 | 1.9% |
| IMMATICS N.V | 12 | Q3 2023 | 0.4% |
| CHINOOK THERAPEUTICS INC | 11 | Q2 2023 | 8.4% |
| ESTABLISHMENT LABS HLDGS INC | 11 | Q3 2023 | 8.3% |
| VINCERX PHARMA INC | 11 | Q2 2023 | 4.5% |
| ASCENDIS PHARMA A/S | 11 | Q3 2023 | 4.9% |
| CYTOKINETICS INC | 11 | Q3 2023 | 2.6% |
| INARI MED INC | 10 | Q1 2023 | 6.4% |
View Affinity Asset Advisors, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Aeglea BioTherapeutics, Inc. | July 03, 2023 | 7,477,000 | 9.2% |
View Affinity Asset Advisors, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-05-07 |
| 13F-HR | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR/A | 2023-08-21 |
| 13F-HR | 2023-08-14 |
| SC 13G | 2023-07-03 |
| 13F-HR | 2023-05-15 |
View Affinity Asset Advisors, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.